145 related articles for article (PubMed ID: 20671585)
1. Association of LOC387715 A69S genotype with visual prognosis after photodynamic therapy for polypoidal choroidal vasculopathy.
Sakurada Y; Kubota T; Imasawa M; Mabuchi F; Tanabe N; Iijima H
Retina; 2010; 30(10):1616-21. PubMed ID: 20671585
[TBL] [Abstract][Full Text] [Related]
2. LOC387715/HTRA1 variants and the response to combined photodynamic therapy with intravitreal bevacizumab for polypoidal choroidal vasculopathy.
Park DH; Kim IT
Retina; 2012 Feb; 32(2):299-307. PubMed ID: 21817962
[TBL] [Abstract][Full Text] [Related]
3. Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy.
Otani A; Sasahara M; Yodoi Y; Aikawa H; Tamura H; Tsujikawa A; Yoshimura N
Am J Ophthalmol; 2007 Jul; 144(1):7-14. PubMed ID: 17467649
[TBL] [Abstract][Full Text] [Related]
4. One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.
Gomi F; Ohji M; Sayanagi K; Sawa M; Sakaguchi H; Oshima Y; Ikuno Y; Tano Y
Ophthalmology; 2008 Jan; 115(1):141-6. PubMed ID: 17582498
[TBL] [Abstract][Full Text] [Related]
5. Reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.
Chhablani J
Am J Ophthalmol; 2010 Sep; 150(3):443-4; author reply 444. PubMed ID: 20728684
[No Abstract] [Full Text] [Related]
6. Intravitreal ranibizumab combined with verteporfin photodynamic therapy for treating polypoidal choroidal vasculopathy.
Lee YH; Lee EK; Shin KS; Lee KM; Kim JY
Retina; 2011; 31(7):1287-93. PubMed ID: 21386762
[TBL] [Abstract][Full Text] [Related]
7. Angiographic lesion size associated with LOC387715 A69S genotype in subfoveal polypoidal choroidal vasculopathy.
Sakurada Y; Kubota T; Imasawa M; Tsumura T; Mabuchi F; Tanabe N; Iijima H
Retina; 2009; 29(10):1522-6. PubMed ID: 19898184
[TBL] [Abstract][Full Text] [Related]
8. One-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.
Yamashita A; Shiraga F; Shiragami C; Ono A; Tenkumo K
Am J Ophthalmol; 2010 Mar; 149(3):465-71.e1. PubMed ID: 20042180
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy with verteporfin in polypoidal choroidal vasculopathy: results after 3 years of follow-up.
Leal S; Silva R; Figueira J; Cachulo ML; Pires I; de Abreu JR; Cunha-Vaz JG
Retina; 2010 Sep; 30(8):1197-205. PubMed ID: 20827139
[TBL] [Abstract][Full Text] [Related]
10. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for polypoidal choroidal vasculopathy.
Sato T; Kishi S; Matsumoto H; Mukai R
Am J Ophthalmol; 2010 Jun; 149(6):947-954.e1. PubMed ID: 20346441
[TBL] [Abstract][Full Text] [Related]
11. Two-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.
Yamashita A; Shiraga F; Shiragami C; Shirakata Y; Fujiwara A
Am J Ophthalmol; 2013 Jan; 155(1):96-102.e1. PubMed ID: 22995028
[TBL] [Abstract][Full Text] [Related]
12. Association of lesion size and visual prognosis to polypoidal choroidal vasculopathy.
Tsujikawa A; Ojima Y; Yamashiro K; Nakata I; Ooto S; Tamura H; Nakanishi H; Hayashi H; Otani A; Yoshimura N
Am J Ophthalmol; 2011 Jun; 151(6):961-972.e1. PubMed ID: 21457926
[TBL] [Abstract][Full Text] [Related]
13. Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy.
Hirami Y; Tsujikawa A; Otani A; Yodoi Y; Aikawa H; Mandai M; Yoshimura N
Retina; 2007 Mar; 27(3):335-41. PubMed ID: 17460589
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and follow-up results of pulsating polypoidal choroidal vasculopathy treated with photodynamic therapy.
Byeon SH; Lew YJ; Lee SC; Kwon OW
Acta Ophthalmol; 2010 Sep; 88(6):660-8. PubMed ID: 19563374
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of photodynamic therapy of polypoidal choroidal vasculopathy.
Akaza E; Mori R; Yuzawa M
Retina; 2008 May; 28(5):717-22. PubMed ID: 18463515
[TBL] [Abstract][Full Text] [Related]
16. Two-year results of photodynamic therapy for polypoidal choroidal vasculopathy.
Kurashige Y; Otani A; Sasahara M; Yodoi Y; Tamura H; Tsujikawa A; Yoshimura N
Am J Ophthalmol; 2008 Oct; 146(4):513-519. PubMed ID: 18614133
[TBL] [Abstract][Full Text] [Related]
17. Central retinal sensitivity measured with the micro perimeter 1 after photodynamic therapy for polypoidal choroidal vasculopathy.
Yodoi Y; Tsujikawa A; Kameda T; Otani A; Tamura H; Mandai M; Yoshimura N
Am J Ophthalmol; 2007 Jun; 143(6):984-994. PubMed ID: 17336913
[TBL] [Abstract][Full Text] [Related]
18. Extensive submacular haemorrhage in polypoidal choroidal vasculopathy managed by sequential gas displacement and photodynamic therapy: a pilot study of one-year follow up.
Chan WM; Liu DT; Lai TY; Li H; Tong JP; Lam DS
Clin Exp Ophthalmol; 2005 Dec; 33(6):611-8. PubMed ID: 16402954
[TBL] [Abstract][Full Text] [Related]
19. Marked vascular changes of polypoidal choroidal vasculopathy after photodynamic therapy.
Wakabayashi T; Gomi F; Sawa M; Tsujikawa M; Tano Y
Br J Ophthalmol; 2008 Jul; 92(7):936-40. PubMed ID: 18577645
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy.
Gomi F; Sawa M; Wakabayashi T; Sasamoto Y; Suzuki M; Tsujikawa M
Am J Ophthalmol; 2010 Jul; 150(1):48-54.e1. PubMed ID: 20609707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
